How many insider trades does FilingIQ track for DERM?

FilingIQ tracks 462 Form 4 insider transactions for DERM (Journey Medical Corp), covering filings from Jun 11, 2015 onwards. 6 of those were filed in the last 90 days.

Are DERM insiders net buyers or net sellers?

Across the full Form 4 history for DERM, 17 transactions (4%) were open-market purchases and 91 (20%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does DERM insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is DERM in?

Journey Medical Corp (DERM) is classified in the Healthcare sector, specifically Drug Manufacturers - Specialty & Generic, with a current market capitalisation of $171.27M.

DERM insider trading

NasdaqCM Healthcare

Journey Medical Corp — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

462

Last 90 days

Buys / sells

4% / 20%

Market cap

$171.27M

About Journey Medical Corp

Journey Medical Corporation, a commercial-stage pharmaceutical company that focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat severe recalcitrant nodular acne; and Amzeeq, a topical formulation of minocycline for the treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris. It also provides Zilxi, a topical minocycline treatment for inflammatory lesions of rosacea; Emrosi for the treatment of inflammatory lesions of rosacea; Exelderm cream and solution for the treatment of fungal skin infections; and Targadox, an oral doxycycline drug for adjunctive therapy for severe acne, as well as Luxamend, a water-based emulsion formulated to provide a moist healing environment for superficial wounds; minor cuts or scrapes; dermal ulcers; donor sites; first- and second-degree burns, including sunburns; and radiation dermatitis. The company was formerly known as Coronado Dermatology, Inc. Journey Medical Corporation was incorporated in 2014 and is headquartered in Scottsdale, Arizona.

Company website: journeymedicalcorp.com

DERM insider activity at a glance

FilingIQ has scored 462 insider transactions for DERM since Jun 11, 2015. The most recent filing in our index is dated Apr 22, 2026.

Across the full history, 17 open-market purchases and 91 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on DERM insider trades is 58.5/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live DERM trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

13F funds holding DERM

Opaleye Management Inc.

$7.52M · 1.0% of AUM

B. Riley Financial, Inc. (RILY, RILYG, RILYK, RILYL, RILYM, RILYN, RILYP, RILYT, RILYZ)

$1.66M · 0.4% of AUM

Frequently asked

How many insider trades does FilingIQ track for DERM?: FilingIQ tracks 462 Form 4 insider transactions for DERM (Journey Medical Corp), covering filings from Jun 11, 2015 onwards. 6 of those were filed in the last 90 days.
Are DERM insiders net buyers or net sellers?: Across the full Form 4 history for DERM, 17 transactions (4%) were open-market purchases and 91 (20%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does DERM insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is DERM in?: Journey Medical Corp (DERM) is classified in the Healthcare sector, specifically Drug Manufacturers - Specialty & Generic, with a current market capitalisation of $171.27M.

Methodology & sources

Every DERM insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.